Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Investigating Age-Related Macular Degeneration
This entry reports a completed clinical trial on age-related macular degeneration sponsored by the National Eye Institute. The snippet does …
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD [Phase 2]
A Phase 2 trial comparing sirolimus to anti-VEGF therapy for wet age-related macular degeneration has completed, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 clinical trial comparing ranibizumab monotherapy with ranibizumab in combination therapies for recurrent or persistent choroidal neo…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Sparing of the Fovea in Geographic Atrophy Progression
Clinical trial update on strategies to spare the fovea during geographic atrophy progression. The study involves conditions including geogra…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of GSK933776 in adults with geographic atrophy due to age-related macular degenera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Squalamine ophthalmic solution in neovascular age-related macular degeneration.…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration [Phase 2]
This clinical trial update reports the Phase 2 results of abicipar pegol in Japanese patients with neovascular age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) [Phase 1]
A Phase I dose-escalation safety study of RetinoStat for advanced age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Reading Performance With a Video Magnifier
A completed clinical trial evaluating reading performance for individuals with age-related macular degeneration using a video magnifier.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels
This clinical trial update reports on flicker fusion thresholds across multiple luminance levels, comparing younger and older subjects and i…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Mobile Clinic - a Cross-sectional Epidemiological Survey
A completed cross-sectional epidemiological survey on age-related macular degeneration, sponsored by Novartis Slovakia.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD) [Phase 4]
This Phase 4 trial update compares ranibizumab and aflibercept to study systemic anti-VEGF effects in neovascular age-related macular degene…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: The Impact of Ocular Diseases on Driving: a Prospective Study
A completed prospective study evaluating how age-related macular degeneration and glaucoma affect driving ability.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD) [Phase 4]
Phase 4 clinical trial evaluating Eylea (aflibercept) for retinal pigment epithelium detachment secondary to age-related macular degeneratio…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) [Phase 1, Phase 2]
This terminated Phase 1/2 trial (Super-dose Anti-VEGF SAVE Trial) evaluated intravitreal 2.0 mg ranibizumab for chronic OCT fluid after prio…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: Study for Recalcitrant Age Related Macular Degeneration [Phase 4]
This update notes the completion of a Phase 4 study for recalcitrant age-related macular degeneration and that the study results have been p…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD [Phase 3]
A Phase 3 randomized study evaluated ranibizumab 0.5 mg using treat-extend and monthly regimens in neovascular age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration [NA]
This clinical trial update reports on the effect of omega-3 fatty acids on blood levels in patients with age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: HELP Therapy for Dry AMD [NA]
This document provides a completed clinical trial update for HELP Therapy targeting dry age-related macular degeneration, sponsored by B.Bra…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) [Phase 3]
This clinical trial update reports efficacy and safety results from the EXTEND III Phase 3 study of ranibizumab in patients with subfoveal c…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration [Phase 1]
A Phase 1 study of RO6867461 in single- and multiple-ascending dose cohorts for wet age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD [Phase 4]
This entry updates on a Phase 4 clinical trial examining genetic factors linked to non-response to anti-VEGF therapy in exudative age-relate…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Tracking Optical Coherence Tomography
Clinical trial update noting the completed status of a study tracking Optical Coherence Tomography, sponsored by the University of Pittsburg…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD [Phase 2]
Phase 2 efficacy and safety study of iSONEP with or without anti-VEGF therapies (Lucentis, Avastin, Eylea) for wet age-related macular degen…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration
This clinical trial update reports the PIIR study, which compares genetic tests for age-related macular degeneration and has been terminated…